Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy

J Clin Oncol. 2001 Mar 1;19(5):1583-5. doi: 10.1200/JCO.2001.19.5.1583.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Age Factors
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Infections / etiology
  • Neutropenia / complications
  • Neutropenia / etiology*
  • Practice Guidelines as Topic
  • Prednisone / administration & dosage
  • Risk Factors
  • Vincristine / administration & dosage

Substances

  • Granulocyte Colony-Stimulating Factor
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol